实体器官移植患者初次全髋关节置换术后内科并发症风险增加:匹配队列分析
该回顾性数据库研究通过倾向性匹配比较有实体器官移植(SOT)史与无SOT史患者初次全髋关节置换术(THA)后的结局。SOT组90天内肾功能衰竭、贫血、心律失常、输血、蜂窝织炎、心肌梗死、肺炎、心力衰竭和脓毒症风险显著升高,但2年手术翻修率无显著差异。
要点
- SOT史患者THA后90天内内科并发症风险显著增加。
- SOT史患者2年手术翻修率与对照无显著差异。
- 围手术期需重点关注心肺、肾脏、血液及感染并发症。
核心结论
- 有SOT史的患者初次THA后90天内内科并发症风险增加,但2年手术并发症或翻修风险未增加。
研究设计与样本
- 回顾性数据库研究,使用全国全付款人索赔数据库(PearlDiver Technologies),纳入2010至2018年间有SOT史且行初次THA的患者,按年龄、性别、Charlson合并症指数和肥胖进行倾向性匹配,比较90天术后并发症和2年手术并发症。
主要发现
- 匹配后SOT组3103例,对照组6196例,两组人口学和合并症无差异。
- SOT组90天内肾功能衰竭(P < .001)、贫血(P < .001)、心律失常伴或不伴房颤(P < .001)、输血(P < .001)、蜂窝织炎(P = .048)、心肌梗死(P < .001)、肺炎(P = .036)、心力衰竭(P < .001)和脓毒症(P = .038)风险显著高于对照组。
- 两组2年手术翻修率(无论指征)无显著差异。
关键数值与推荐
- SOT组90天肾功能衰竭P < .001,贫血P < .001,心律失常伴或不伴房颤P < .001,输血P < .001,蜂窝织炎P = .048,心肌梗死P < .001,肺炎P = .036,心力衰竭P < .001,脓毒症P = .038。
- 2年手术翻修率两组无显著差异。
临床怎么用
- 对SOT史患者行初次THA时,应加强围手术期心肺、肾脏、血液和感染并发症的监测与管理。
- 在术前咨询中应告知SOT患者90天内内科并发症风险增加,但2年翻修风险与普通患者相当。
局限性
- 回顾性数据库研究,证据等级为IV级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As patient longevity increases following solid organ transplantation (SOT), more transplant patients are undergoing total hip arthroplasty (THA). The purpose of this study is to compare 90-day postoperative complications and 2-year surgical complications following primary THA in patients with and without a history of SOT. METHODS: Patients with a history of SOT with subsequent primary THA between 2010 and 2018 were identified in a national all-payer claims database (PearlDiver Technologies). This SOT cohort was propensity-matched with a control cohort (no history of SOT) based on age, gender, Charlson Comorbidity Index, and obesity with bivariate analysis to compare outcomes between cohorts. RESULTS: Following matching, 3103 patients were included in the SOT cohort and 6196 patients in the control cohort. The cohorts were successfully matched, with no differences in demographics or comorbidities. Relative to the control cohort, patients with a history of SOT were at significantly increased risk of renal failure (P < .001), anemia (P < .001), arrhythmia with and without atrial fibrillation (P < .001), blood transfusion (P < .001), cellulitis (P = .048), myocardial infarction (P < .001), pneumonia (P = .036), heart failure (P < .001), and sepsis (P = .038) at 90 days postoperatively. There were no significant differences between the cohorts in 2-year surgical revisions, regardless of indication. CONCLUSION: Following primary THA, patients with a history of SOT are at increased risk of 90-day medical complications but not 2-year surgical complications or revisions relative to patients without SOT. Clinicians should be mindful of the increased risk for cardiopulmonary, renal, hematologic, and infectious complications when counseling and managing this patient population. LEVEL OF EVIDENCE: Level IV-Retrospective Database Study.
引用
- Agarwal AR, Gu A, Mawn JG, et al. Increased Medical Complications Following Primary Total Hip Arthroplasty in Patients With Solid Organ Transplant: A Matched Cohort Analysis. J Arthroplasty. 2021. PMID: 34602318. doi:10.1016/j.arth.2021.08.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。